Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myo-inositol

NeuroReport

Volumn 18, Issue 15, 2007, Pages 1595-1598

  McGrath, Brent M ^a,b   Greenshaw, Andrew J ^a   McKay, Ryan ^a   Slupsky, Carolyn M ^a   Silverstone, Peter H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Anticonvulsants; Antidepressants; Bipolar disorder; Inositol depletion; Magnetic resonance spectroscopy; Mood stabilizers; Regional brain changes

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BRAIN ENZYME; CARBAMAZEPINE; DESIPRAMINE; DRUG VEHICLE; FLUOXETINE; INOSITOL; LAMOTRIGINE; LITHIUM; PHENELZINE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; BRAIN REGION; COMPUTER PROGRAM; CONTROLLED STUDY; DISSECTION; DRUG BRAIN LEVEL; HIPPOCAMPUS; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCIPITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; TEMPORAL CORTEX;

ANIMALS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BRAIN CHEMISTRY; CARBAMAZEPINE; CEREBRAL CORTEX; HIPPOCAMPUS; INOSITOL; LITHIUM CARBONATE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; RATS; RATS, SPRAGUE-DAWLEY; TRIAZINES; VALPROIC ACID;

EID: 34748850702     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3282f03f09     Document Type: Article

References (23)

1. Fieve RR. Lithium therapy at the millennium: a revolutionary drug used for 50 years faces competing options and possible demise. Bipolar Disord 1999; 1:67-70.
2. Post RM, Weiss SRB, Clark M, Chuang DM, Hough C, Li H. Lithium, carbamazepine, and valproate in affective illness. In: Manji H, Bowden CL, Belmaker RH, editors. Bipolar medications: mechanisms of action. Washington, DC: American Psychiatric Press Inc.; 2000. pp. 219-249.
3. Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, et al., and the Lamictal 605 Study Group. A vehicle-controlled 18-month trail of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003; 64:1013-1024.
4. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 2004; 161:1537-1547.
5. Sachs GS, Nierenberg AA, Calabrese JR. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356: 1711-1722.
6. Allison JH, Stewart MA. Reduced brain inositol in lithium-treated rats. Nature New Biol 1971; 233:267-268.
7. O'Donnell T, Rotzinger S, Nakashima TT, Hanstock CC, Ulrich M, Silverstone PH. Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain. Brain Res 2000; 880:84-91.
8. McGrath BM, Greenshaw AJ, McKay R, Slupsky CM, Silverstone PH. Lithium alters regional rat brain myo-inositol at 2 and 4 weeks: an ex vivo MRS study at 18.8 Tesla. NeuroReport 2006; 17:1323-1326.
9. Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients. Hum Psychopharmacol Clin Exp 2002; 17:321-327.
10. Castel-Branco M, Lebre V, Falcao A, Figueiredo I, Caramona M. Relationship between plasma and brain levels and the anticonvulsant effect of lamotrigine in rats. Eur J Pharmacol 2003; 482:163-168.
11. Hasegawa H, Osada K, Misonoo A, Morinobu S, Yamamoto H, Miyamoto E, Asakura M. Chronic carbamazepine treatment increases myristoylated alanine-rich C kinase substrate phosphorylation in the rat cerebral cortex via down-regulation of calcineurin Aα. Brain Res 2003; 994:19-26.
12. Shaltiel G, Shamir A, Shapiro J, Ding D, Dalton E, Bialer M, et al. Valproate decreases inositol biosynthesis. Biol Psychiatry 2004; 56:868-874.
13. Dwivedi Y, Agrawal AK, Rizavi HS, Pandey GN. Antidepressants reduce phosphoinositide-specific phospholipase C (PI-PLC) activity and the mRNA and protein expression of selective PLC β1 isozyme in rat brain. Neuropharmacol 2002; 43:1269-1279.
14. Okada F, Tokumitou Y, Ui M. Possible involvement of pertussis toxin substrates (Gi, Go) in desipramine-induced refractoriness of adenylate cyclase in cerebral cortices of rats. J Neurochem 1988; 51:194-199.
15. Todd KG, McManus DJ, Baker GB. Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decrease binding of 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain. Cell Mol Neurobiol 1995; 15:361-370.
16. Pellegrino LJ, Pellegrino AS, Cushman AJ. A stereotaxic atlas of the rat brain. 2nd ed. New York, New York: Plenum Press; 1979. pp. 1-35.
17. Vaden DL, Ding D, Peterson B, Greenberg ML. Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis. J Biol Chem 2001; 276:15466-15471.
18. Cheng L, Lumb M, Polgar L, Mudge AW. How can the mood stabilizer VPA limit both mania and depression? Mol Cell Neurosci 2005; 29:155-161.
19. Schulz I, Gerhartz B, Neubauer A, Holloschi A, Heiser U, Hafner M, Demuth HU. Modulation of inositol 1,4,5-trisphosphate concentration by prolyl endopeptidase inhibition. Eur J Biochem 2002; 269:5813-5820.
20. Breen G, Harwood AJ, Gregory K, Sinclair M, Collier D, St. Clair D, Williams RS. Two peptidase activities decrease in treated bipolar disorder not schizophrenic patients. Bipolar Disord 2004; 6:156-161.
21. Pinna G, Costa E, Guidotti A. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacol 2006; 186:362-372.
22. Goodnough DB, Baker GB. 5-Hydroxytryptamine 2 and β-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination. J Neurochem 1994; 62:2262-2268.
23. Subhash MN, Jagadeesh S. Imipramine-induced changes in 5-HT2 receptor sites and inositoltrisphosphate levels in rat brain. Neurochem Res 1997; 22:1095-1099.